HIGHLIGHTS
- who: E. Oki from the Department of Surgery and Science, Kyushu University Graduate School of Medical Sciences, FukuokaSurgeries, Tokyo Medical and Dental University, Tokyo have published the research work: Impact of the 12-gene recurrence score assay on deciding adjuvant chemotherapy for stage II and IIIA/B colon cancer: the SUNRISE-DI study, in the Journal: (JOURNAL)
- what: The aim was to estimate the rate of change in treatment recommendations from before to after the assay. Third, the patient registration in this study had started before the results of the IDEA collaboration for high-risk . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.